Skip to Content

8,790 Results Found

  • Article
  • Open Access
2,288 Views
17 Pages

SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma

  • Karolina Buchholz,
  • Justyna Durślewicz,
  • Anna Klimaszewska-Wiśniewska,
  • Magdalena Wiśniewska and ,
  • Maciej Słupski and
  • Dariusz Grzanka
  • + 1 author+ 0 author

The spindle and kinetochore-associated complex subunit 3 (SKA3) is a protein essential for proper chromosome segregation during mitosis and thus responsible for maintaining genome stability. Although its involvement in the pathogenesis of various can...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
5 Citations
3,097 Views
13 Pages

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?

  • Aneta Cymbaluk-Płoska,
  • Paula Gargulińska,
  • Sebastian Kwiatkowski,
  • Ewa Pius-Sadowska and
  • Bogusław Machaliński

Galectin 3 is a modulator of several basic biological functions. It may be involved in the development of obesity and type 2 diabetes—risk factors of endometrial cancer. The study involved 144 patients, after abrasion due to postmenopausal blee...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
2 Citations
1,497 Views
10 Pages

Increased Pre-Operative Lung Immune Prognostic Index Score Is a Prognostic Factor in Cases of Pathological T3 Renal Cell Carcinoma

  • Hayato Hoshina,
  • Toru Sugihara,
  • Masayuki Kurokawa,
  • Ei-ichiro Takaoka and ,
  • Satoshi Ando,
  • Haruki Kume and
  • Tetsuya Fujimura
  • + 2 authors+ 0 author

We assessed the efficacy of the lung immune prognostic index (LIPI) in predicting the progression of pathological T3 renal cell carcinoma (RCC). The LIPI scores of patients with pathological T3 RCC were calculated in the pre- and post-operative phase...

(This article belongs to the Section Surgical Oncology)
  • Review
  • Open Access
117 Citations
8,536 Views
25 Pages

13 April 2020

Inflammatory blood markers (IBM), such as the neutrophil to lymphocyte ratio (NLR), have emerged as potential prognostic factors in various cancers, including breast cancer (BC), potentially allowing an easy, minimally invasive evaluation of a given...

  • Article
  • Open Access
15 Citations
3,473 Views
12 Pages

Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience

  • Paulina Jagodzińska-Mucha,
  • Anna Raciborska,
  • Hanna Koseła-Paterczyk,
  • Katarzyna Kozak and ,
  • Katarzyna Bilska,
  • Tomasz Świtaj,
  • Sławomir Falkowski,
  • Anna Dawidowska,
  • Piotr Rutkowski and
  • Iwona Ługowska
  • + 5 authors+ 0 author

17 August 2021

Ewing sarcoma (ES) is a rare and aggressive disease that requires multidisciplinary treatment with the use of chemotherapy, radiotherapy, and surgery. Our retrospective study aimed to analyze the prognostic factors and treatment results in different...

(This article belongs to the Section Oncology)
  • Systematic Review
  • Open Access
4 Citations
4,123 Views
21 Pages

This study aims to provide an overview of multivariable prognostic modelling studies developed for coronary heart disease (CHD) in the general population and to explore the optimal prognostic model by comparing the models’ performance. A system...

(This article belongs to the Topic Biomarkers in Cardiovascular Disease—Chances and Risks)
  • Article
  • Open Access
3 Citations
3,686 Views
9 Pages

Sex as a Prognostic Factor in Systematic Reviews: Challenges and Lessons Learned

  • Elena Stallings,
  • Alba Antequera,
  • Jesús López-Alcalde,
  • Miguel García-Martín and ,
  • Gerard Urrútia and
  • Javier Zamora
  • + 1 author+ 0 author

Sex is a common baseline factor collected in studies that has the potential to be a prognostic factor (PF) in several clinical areas. In recent years, research on sex as a PF has increased; however, this influx of new studies frequently shows conflic...

(This article belongs to the Special Issue Personalizing Medicine by Sex, Gender and Hormonal Status: Progress, Opportunities and Challenges)
  • Article
  • Open Access
10 Citations
3,099 Views
18 Pages

Immunohistochemical Evaluation of FGD3 Expression: A New Strong Prognostic Factor in Invasive Breast Cancer

  • Tommaso Susini,
  • Giulia Saccardin,
  • Irene Renda,
  • Milo Giani and ,
  • Enrico Tartarotti,
  • Jacopo Nori,
  • Ermanno Vanzi,
  • Elisa Pasqualini and
  • Simonetta Bianchi
  • + 4 authors+ 0 author

29 July 2021

Among new prognostic factors for breast cancer, the most promising one seems to be FGD3 (Facio-Genital Dysplasia 3) gene, whose expression improves outcome by inhibiting cell migration. The aim of the study was to evaluate the prognostic role of FGD3...

(This article belongs to the Special Issue Prognostic Factors Research in Breast Cancer Patients)
  • Article
  • Open Access
25 Citations
7,015 Views
10 Pages

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients

  • Helene Heidegger,
  • Sebastian Dietlmeier,
  • Yao Ye,
  • Christina Kuhn and ,
  • Aurelia Vattai,
  • Caroline Aberl,
  • Udo Jeschke,
  • Sven Mahner and
  • Bernd Kost
  • + 4 authors+ 0 author

We know that one of the main risk factors for cervical cancer is an infection with high-risk human papillomavirus (HR-HPV). Prostaglandins and their receptors are very important for the tumour growth and tumour-associated angiogenesis. Little is know...

(This article belongs to the Special Issue Gynecologic Oncology: From Molecular Mechanisms to Targeted Therapies)
  • Review
  • Open Access
8 Citations
3,895 Views
33 Pages

Background/Objectives: Sarcopenia, defined as the progressive loss of muscle mass and function, is increasingly associated with worse outcomes in the surgical treatment of colorectal cancer (CRC). This paper focuses on analyzing the impact of sarcope...

  • Article
  • Open Access
4 Citations
2,570 Views
20 Pages

Evaluation of Tissue Expression of Vaspin and Serum Vaspin Concentration as a Prognostic and Risk Factor in Endometrial Cancer

  • Mateusz Kozłowski,
  • Dominika Pietrzyk,
  • Małgorzata Rychlicka,
  • Katarzyna Piotrowska and ,
  • Katarzyna Nowak,
  • Sebastian Kwiatkowski and
  • Aneta Cymbaluk-Płoska
  • + 2 authors+ 0 author

11 October 2022

Adipose tissue is a multifunctional endocrine organ. One of the biologically active substances is vaspin, which is part of the serpin family. The purpose of the following study is to determine the possibility of using vaspin as a prognostic and risk...

(This article belongs to the Special Issue Diagnostic, Prognostic and Therapeutic Biomarkers Related to Civilization Diseases: State-of-the-Art)
  • Article
  • Open Access
3 Citations
2,727 Views
18 Pages

Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy

  • Diana Cornelia Moisuc,
  • Daniela Constantinescu,
  • Mihai Vasile Marinca,
  • Bogdan Gafton and ,
  • Mariana Pavel-Tanasa and
  • Petru Cianga
  • + 1 author+ 0 author

16 January 2024

Colorectal cancer (CRC) ranks as second most common cause of cancer-related deaths. The CRC management considerably improved in recent years, especially due to biological therapies such as bevacizumab. The lack of predictive or prognostic biomarkers...

(This article belongs to the Special Issue Metastatic Colorectal Cancer 2.0)
  • Article
  • Open Access
5 Citations
4,120 Views
13 Pages

Hyponatremia—Long-Term Prognostic Factor for Nonfatal Pulmonary Embolism

  • Anca Ouatu,
  • Madalina Stefana Mihai,
  • Daniela Maria Tanase,
  • Cristina Gena Dascalu and ,
  • Nicoleta Dima,
  • Lacramioara Ionela Serban,
  • Ciprian Rezus and
  • Mariana Floria
  • + 3 authors+ 0 author

Over recent years, studies have shown that in patients with left-sided heart failure, arterial hypertension, and acute coronary syndrome, hyponatremia is a negative prognostic factor. In this context, there is raising interest in the association betw...

(This article belongs to the Special Issue Cardiovascular Diseases: Diagnosis, Treatment, and Management—for the Up-to-Date Practitioner)
  • Article
  • Open Access
66 Citations
9,099 Views
14 Pages

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study

  • Mateusz Szylberg,
  • Paweł Sokal,
  • Paulina Śledzińska,
  • Marek Bebyn and ,
  • Stanisław Krajewski,
  • Łukasz Szylberg,
  • Aneta Szylberg,
  • Tadeusz Szylberg,
  • Kamil Krystkiewicz and
  • Jacek Furtak
  • + 8 authors+ 3 authors

Glioblastoma is the most malignant central nervous system tumor, which represents 50% of all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment planning has been significantly enhanced by the discovery of molecula...

(This article belongs to the Special Issue State-of-the-Art Cancer Biology and Therapeutics in Poland)
  • Article
  • Open Access
4 Citations
3,788 Views
15 Pages

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

  • Neus Martínez-Bosch,
  • Noelia Vilariño,
  • Francesc Alameda,
  • Sergi Mojal and ,
  • Montserrat Arumí-Uria,
  • Cristina Carrato,
  • Iban Aldecoa,
  • Teresa Ribalta,
  • Noemí Vidal and
  • Pilar Navarro
  • + 17 authors+ 12 authors

8 March 2023

Glioblastoma (GBM) is the most frequent primary malignant brain tumor and has a dismal prognosis. Unfortunately, despite the recent revolution of immune checkpoint inhibitors in many solid tumors, these have not shown a benefit in overall survival in...

(This article belongs to the Special Issue Galectins in Health and Disease)
  • Article
  • Open Access
1 Citations
1,837 Views
13 Pages

Sarcopenia Is a Prognostic Factor in Patients Undergoing Percutaneous Endoscopic Gastrostomy

  • Shingo Ono,
  • Hiroto Furuhashi,
  • Shunsuke Kisaki,
  • Hideka Horiuchi and ,
  • Hiroaki Matsui,
  • Akira Dobashi,
  • Hiroya Ojiri and
  • Kazuki Sumiyama
  • + 3 authors+ 0 author

9 May 2023

(1) Background: Percutaneous endoscopic gastrostomy (PEG) is a widely used long-term enteral nutrition method, but little is known about the associated prognostic factors in patients with PEG. Sarcopenia, a condition characterized by a loss of skelet...

(This article belongs to the Special Issue 10th Anniversary of JCM—Recent Diagnostic and Therapeutic Advance in Gastroenterology and Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
2 Citations
3,353 Views
8 Pages

Investigating a Prognostic Factor for Canine Hepatocellular Carcinoma: Analysis of Different Histological Grading Systems and the Role of PIVKA-II

  • Lorella Maniscalco,
  • Katia Varello,
  • Emanuela Morello,
  • Vittoria Montemurro and ,
  • Matteo Olimpo,
  • Davide Giacobino,
  • Giuseppina Abbamonte,
  • Cecilia Gola,
  • Selina Iussich and
  • Elena Bozzetta
  • + 5 authors+ 0 author

10 December 2022

Background: Hepatocellular carcinoma (HCC) in dogs is uncommon and often associated with a good prognosis, although some cases prove to be aggressive. In human oncology HCC is often very aggressive and diagnostic methods and prognostic factors are wi...

(This article belongs to the Special Issue Comparative Pathology of Cancers in Animals)
  • Article
  • Open Access
6 Citations
3,854 Views
16 Pages

Antiangiogenic Drug-Induced Proteinuria as a Prognostic Factor in Metastatic Colorectal Cancer

  • Diana Cornelia Moisuc,
  • Mihai Vasile Marinca,
  • Bogdan Gafton,
  • Teodora Alexa-Stratulat and ,
  • Mariana Pavel-Tanasa and
  • Petru Cianga
  • + 1 author+ 0 author

31 May 2022

Treatment with bevacizumab is known to cause adverse events such as proteinuria and hypertension, amongst others. However, while bevacizumab-induced hypertension has been linked to increased overall survival (OS), data on proteinuria are controversia...

  • Article
  • Open Access
27 Citations
7,004 Views
16 Pages

GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature

  • Patrizia Querzoli,
  • Massimo Pedriali,
  • Rosa Rinaldi,
  • Paola Secchiero and ,
  • Paolo Giorgi Rossi and
  • Elisabetta Kuhn
  • + 1 author+ 0 author

Background: GATA binding protein 3 (GATA3) expression is positively correlated with estrogen receptor (ER) expression, but its prognostic value as an independent factor remains unclear. Thus, we undertook the current study to evaluate the expression...

(This article belongs to the Special Issue Tissue-Based Biomarkers of Solid Tumors in the Routine Clinical Setting)
  • Article
  • Open Access
7 Citations
3,594 Views
9 Pages

Prognostic Factor of Lower Limb Amputation among Diabetic Foot Ulcer Patients in North-East Peninsular Malaysia

  • Anas Rosedi,
  • Suhaily Mohd Hairon,
  • Noor Hashimah Abdullah and
  • Nor Azwany Yaacob

Lower limb amputation (LLA) is a common complication of diabetic foot ulcer (DFU), which can lead to a higher 5-year mortality rate compared to all cancers combined. This study aimed to determine the prognostic factors of LLA among DFU patients in Ke...

(This article belongs to the Section Public Health Statistics and Risk Assessment)
  • Article
  • Open Access
15 Citations
4,110 Views
14 Pages

The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy

  • Olivia Knittelfelder,
  • Daniela Delago,
  • Gabriele Jakse,
  • Katarzyna Lukasiak and ,
  • Eva-Maria Thurner,
  • Dietmar Thurnher,
  • Martin Pichler,
  • Wilfried Renner,
  • Heidi Stranzl-Lawatsch and
  • Tanja Langsenlehner
  • + 5 authors+ 0 author

8 March 2020

The purpose of the present study was to evaluate the prognostic significance of the pre- treatment C-reactive protein (CRP) level in a cohort of 503 patients with oral and oropharyngeal cancer treated at a tertiary academic center between 2000 and 20...

(This article belongs to the Special Issue C-Reactive Protein in Cancer)
  • Article
  • Open Access
1 Citations
2,179 Views
11 Pages

C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCC

  • Frederic Jungbauer,
  • Claudia Scherl,
  • Nicole Rotter,
  • Annette Affolter and ,
  • Anne Lammert,
  • Elena Seiz,
  • Margot Thiaucourt and
  • Lena Huber
  • + 3 authors+ 0 author

30 June 2024

Introduction The kinetic of C-reactive protein (CRP) in the early phase of therapy with checkpoint inhibitors (CPI) and its prognostic value has already been investigated in several tumor entities. In particular, flare dynamics have been described as...

  • Article
  • Open Access
4 Citations
7,526 Views
17 Pages

Overall Survival and Prognostic Factors in De Novo Metastatic Human Epidermal Growth Factor Receptor (HER)-2-Positive Breast Cancer: A National Cancer Database Analysis

  • Meghana Kesireddy,
  • Durva Masih,
  • Valerie K. Shostrom,
  • Amulya Yellala and ,
  • Samia Asif and
  • Jairam Krishnamurthy
  • + 1 author+ 0 author

30 May 2025

Background: About 15–20% of breast cancers are HER2 positive. Approximately 15–24% of individuals with localized HER2-positive cancer develop metastatic disease after curative treatment, while 3–10% present with de novo metastasis....

(This article belongs to the Special Issue Advances in Invasive Breast Cancer: Treatment and Prognosis (2nd Edition))
  • Article
  • Open Access
6 Citations
3,848 Views
18 Pages

Lymph but Not Blood Vessel Invasion Is Independent Prognostic in Lung Cancer Patients Treated by VATS-Lobectomy and Might Represent a Future Upstaging Factor for Early Stages

  • Melanie Biesinger,
  • Nele Eicken,
  • Alexander Varga,
  • Michael Weber and ,
  • Milos Brndiar,
  • Georg Erd,
  • Peter Errhalt,
  • Klaus Hackner,
  • Sarah Hintermair and
  • Bahil Ghanim
  • + 8 authors+ 3 authors

8 April 2022

Lung cancer is the most frequent cause of cancer-related death worldwide. The patient’s outcome depends on tumor size, lymph node involvement and metastatic spread at the time of diagnosis. The prognostic value of lymph and blood vessel invasio...

(This article belongs to the Special Issue Bio-Pathological Markers for the Diagnosis and Therapy of Cancers, Volume II)
  • Article
  • Open Access
17 Citations
2,496 Views
10 Pages

Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying Covariates

  • Kenji Imai,
  • Koji Takai,
  • Shinji Unome,
  • Takao Miwa and ,
  • Tatsunori Hanai,
  • Atsushi Suetsugu and
  • Masahito Shimizu
  • + 2 authors+ 0 author

23 August 2023

This study aimed to assess the effects of lenvatinib (LEN) or sorafenib (SOR) treatment for hepatocellular carcinoma (HCC) on body composition and changes in body composition on survival. This study enrolled 77 HCC patients. Skeletal muscle index (SM...

(This article belongs to the Special Issue Advances in Cancer Cachexia)
  • Article
  • Open Access
10 Citations
3,421 Views
24 Pages

Glutaredoxin 2 Protein (Grx2) as an Independent Prognostic Factor Associated with the Survival of Colon Adenocarcinoma Patients

  • Marlena Brzozowa-Zasada,
  • Adam Piecuch,
  • Karolina Bajdak-Rusinek,
  • Karolina Gołąbek and ,
  • Marek Michalski,
  • Kamil Janelt and
  • Natalia Matysiak
  • + 2 authors+ 0 author

15 January 2024

Glutaredoxin 2 (Grx2; Glrx2) is a glutathione-dependent oxidoreductase located in mitochondria, which is central to the regulation of glutathione homeostasis and mitochondrial redox, and plays a crucial role in highly metabolic tissues. In response t...

(This article belongs to the Special Issue Advanced Research on Biomarkers in Gastrointestinal Cancer)
  • Systematic Review
  • Open Access
17 Citations
4,993 Views
22 Pages

Risk Factors and Prognostic Factors in GBC

  • Luiza Tirca,
  • Catalin Savin,
  • Cezar Stroescu,
  • Irina Balescu and ,
  • Sorin Petrea,
  • Camelia Diaconu,
  • Bogdan Gaspar,
  • Lucian Pop,
  • Valentin Varlas and
  • Nicolae Bacalbasa
  • + 11 authors+ 6 authors

18 July 2024

Background: Gallbladder cancer (GBC) is a rare entity with a poor prognosis, usually discovered late due to nonspecific symptoms; therefore, over the last years, attention has been focused on identifying the risk factors for developing this malignanc...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
4 Citations
2,593 Views
12 Pages

Prognostic Value of the Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Uveal Melanoma: A Clinico-Pathological and Immunohistochemical Study on a Series of 85 Cases

  • Giuseppe Broggi,
  • Luca Falzone,
  • Matteo Fallico,
  • Andrea Russo and ,
  • Michele Reibaldi,
  • Antonio Longo,
  • Teresio Avitabile,
  • Rocco De Pasquale,
  • Lidia Puzzo and
  • Rosario Caltabiano
  • + 10 authors+ 5 authors

26 August 2021

Uveal melanoma (UM) is the most frequent primary ocular malignancy of adults; it exhibits an almost invariably poor prognosis with onset of liver metastases within 10–15 years after the diagnosis. Serine and arginine-rich splicing factor 1 (SRSF1) is...

(This article belongs to the Special Issue Immunohistochemical Expression Volume II)
  • Article
  • Open Access
3 Citations
2,685 Views
16 Pages

Co-Expression of Chromatin Assembly Factor 1 Subunit A and Proliferating Cell Nuclear Antigen Is a Prognostic Biomarker of Esophageal Cancer

  • Bing Wen,
  • Dan-Xia Deng,
  • Lian-Di Liao,
  • Zhi-Da Zhang and ,
  • Ya-Qi Zheng,
  • Ke Dong,
  • Li-Yan Xu and
  • En-Min Li
  • + 3 authors+ 0 author

(1) Background: Esophageal cancer (EC) is an important global health challenge. Due to the lack of necessary biomarkers and therapeutic targets, the survival of EC patients is poor. The EC proteomic data of 124 patients recently published by our grou...

(This article belongs to the Special Issue The Biomarkers for the Diagnosis, Prognosis and Treatments Response in Digestive Disorders)
  • Article
  • Open Access
7 Citations
2,918 Views
18 Pages

25 May 2022

Treatment decisions in patients with small cell lung cancer (SCLC) are made based on the extent of the disease. However, the outcome varies among patients at the same stage. A simple tool to predict outcomes in SCLC patients would be helpful for clin...

(This article belongs to the Section Cancer Biomarkers)
  • Systematic Review
  • Open Access
4 Citations
2,945 Views
16 Pages

A Systematic Review of Prognostic Factors in Patients with Cancer Receiving Palliative Radiotherapy: Evidence-Based Recommendations

  • Alexander Tam,
  • Emanuela Scarpi,
  • Marco Cesare Maltoni,
  • Romina Rossi and ,
  • Alysa Fairchild,
  • Kristopher Dennis,
  • Marcus Vaska and
  • Marc Kerba
  • + 3 authors+ 0 author

25 April 2024

(1) Background: Prognostication in patients with cancer receiving palliative radiotherapy remains a challenge. To improve the process, we aim to identify prognostic factors in this population from the literature and offer evidence-based recommendatio...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Article
  • Open Access
3,602 Views
12 Pages

Examining the Landscape of Prognostic Factors and Clinical Outcomes for Cancer Control

  • Meredith Elana Giuliani,
  • Eleni Giannopoulos,
  • Mary Krystyna Gospodarowicz,
  • Michaela Broadhurst and ,
  • Brian O’Sullivan,
  • Zuzanna Tittenbrun,
  • Sonali Johnson and
  • James Brierley
  • + 3 authors+ 0 author

6 December 2021

Prognostic factors have important utility in various aspects of cancer surveillance, including research, patient care, and cancer control programmes. Nevertheless, there is heterogeneity in the collection of prognostic factors and outcomes data globa...

  • Review
  • Open Access
51 Citations
6,277 Views
14 Pages

Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment

  • Nicola Montemurro,
  • Bhavya Pahwa,
  • Anish Tayal,
  • Anushruti Shukla and ,
  • Manuel De Jesus Encarnacion,
  • Issael Ramirez,
  • Renat Nurmukhametov,
  • Vishal Chavda and
  • Antonella De Carlo
  • + 4 authors+ 0 author

23 April 2023

Glioblastoma (GBM) is a common and highly malignant primary tumor of the central nervous system in adults. Ever more recent papers are focusing on understanding the role of the tumor microenvironment (TME) in affecting tumorigenesis and the subsequen...

  • Review
  • Open Access
4 Citations
3,400 Views
25 Pages

Tumor Characteristics and Clinical Features of the Patient as Prognostic Factors in PDAC

  • Karina Udrycka,
  • Kamil Rutkowski,
  • Anton Osnytskyy and
  • Ewa Małecka-Wojciesko

17 October 2025

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths among individuals over the age of 50. It is characterized by exceptional aggressiveness and is often diagnosed at an advanced stage, highlighting the importan...

(This article belongs to the Collection Recent Advances in Pancreatic Ductal Adenocarcinoma)
  • Review
  • Open Access
33 Citations
7,567 Views
28 Pages

Immunological Prognostic Factors in Multiple Myeloma

  • Dominika Bębnowska,
  • Rafał Hrynkiewicz,
  • Ewelina Grywalska,
  • Marcin Pasiarski and ,
  • Barbara Sosnowska-Pasiarska,
  • Iwona Smarz-Widelska,
  • Stanisław Góźdź,
  • Jacek Roliński and
  • Paulina Niedźwiedzka-Rystwej
  • + 4 authors+ 0 author

Multiple myeloma (MM) is a plasma cell neoplasm characterized by an abnormal proliferation of clonal, terminally differentiated B lymphocytes. Current approaches for the treatment of MM focus on developing new diagnostic techniques; however, the sear...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
29 Citations
19,821 Views
24 Pages

While canine lymphoma is a relatively common and important disease seen by veterinarians, there are limited comprehensive reviews of the literature regarding the remission and survival times following chemotherapy, and the associated prognostic facto...

  • Article
  • Open Access
5 Citations
3,435 Views
16 Pages

Combining Molecular and Traditional Prognostic Factors: A Holistic Approach to Breast Cancer Prognostication

  • Liviu Moraru,
  • Melinda Ildiko Mitranovici,
  • Raluca Moraru,
  • Septimiu Voidazan and ,
  • Mihai Munteanu,
  • Rares Georgescu,
  • Dan Costachescu and
  • Sabin Gligore Turdean
  • + 3 authors+ 0 author

Breast cancer is a heterogeneous disease with various morphologies and molecular features, and it is the second leading cause of cancer death in women in developed countries. According to the literature, we currently lack both prognostic biomarkers a...

(This article belongs to the Special Issue Clinical Prognostic and Predictive Biomarkers, 2nd Edition)
  • Systematic Review
  • Open Access
13 Citations
6,802 Views
52 Pages

Acanthamoeba Keratitis Management and Prognostic Factors: A Systematic Review

  • Pedro Marques-Couto,
  • Mariana Monteiro,
  • Ana Margarida Ferreira,
  • João Pinheiro-Costa and
  • Rodrigo Vilares-Morgado

7 April 2025

Background/Objectives: The aim of this study was to review the therapeutic and prognostic factors influencing Acanthamoeba Keratitis (AK) management. Methods: A systematic search was performed across MEDLINE® (via PubMed), Web of Science®, an...

(This article belongs to the Section Ophthalmology)
  • Systematic Review
  • Open Access
25 Citations
5,790 Views
17 Pages

Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors: A Systematic Review

  • Oriana D’Ecclesiis,
  • Saverio Caini,
  • Chiara Martinoli,
  • Sara Raimondi and ,
  • Camilla Gaiaschi,
  • Giulio Tosti,
  • Paola Queirolo,
  • Camilla Veneri,
  • Calogero Saieva and
  • Susanna Chiocca
  • + 6 authors+ 1 author

Background and aim: Over the last decades, the incidence of melanoma has been steadily growing, with 4.2% of the population worldwide affected by cutaneous melanoma (CM) in 2020 and with a higher incidence and mortality in men than in women. We inves...

(This article belongs to the Special Issue Lifestyle, Gender and Cancers)
  • Review
  • Open Access
151 Citations
11,632 Views
15 Pages

Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis

  • Giuseppe Maglietta,
  • Francesca Diodati,
  • Matteo Puntoni,
  • Silvia Lazzarelli and ,
  • Barbara Marcomini,
  • Laura Patrizi and
  • Caterina Caminiti
  • + 2 authors+ 0 author

11 March 2022

Evidence shows that a substantial proportion of patients with COVID-19 experiences long-term consequences of the disease, but the predisposing factors are poorly understood. We conducted a systematic review and meta-analysis to identify factors prese...

(This article belongs to the Special Issue Unusual Clinical Presentation of COVID-19)
  • Article
  • Open Access
1 Citations
710 Views
13 Pages

Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma

  • Luca Canali,
  • Francesca Gaino,
  • Claudia Valenziano,
  • Giulio Sandri and ,
  • Alberto Paderno,
  • Fabio Ferreli,
  • Luca Malvezzi,
  • Gherardo Mazziotti,
  • Andrea Lania and
  • Giuseppe Mercante
  • + 6 authors+ 1 author

19 March 2026

Objectives: Medullary thyroid carcinoma (MTC) is a rare but biologically aggressive neuroendocrine tumor for which reliable preoperative prognostic biomarkers are still lacking. This study aimed to evaluate the association between preoperative blood...

(This article belongs to the Special Issue Diagnosis, Treatment and Prognosis of Head and Neck Cancer)
  • Article
  • Open Access
19 Citations
6,422 Views
13 Pages

Prognostic Factors Influencing Survival in Ovarian Cancer Patients: A 10-Year Retrospective Study

  • Maria Andreou,
  • Maria Kyprianidou,
  • Christos Cortas,
  • Irene Polycarpou and ,
  • Demetris Papamichael,
  • Panteleimon Kountourakis and
  • Konstantinos Giannakou
  • + 2 authors+ 0 author

5 December 2023

Objective: To analyze the factors associated with overall survival (OS) and progression-free survival (PFS) in patients with ovarian cancer in Cyprus. Methods: We retrospectively analyzed data from patients with histologically confirmed epithelial ov...

(This article belongs to the Special Issue Quality of Life in Patients with Gynecologic Cancer)
  • Review
  • Open Access
50 Citations
6,280 Views
14 Pages

4 January 2022

Approximately 20% of patients with renal cell carcinoma (RCC) present with primarily metastatic disease and over 30% of patients with localized RCC will develop distant metastases later, after complete resection of the primary tumor. Accurate postope...

(This article belongs to the Special Issue Clear Cell Renal Cell Carcinoma 2021–2022)
  • Article
  • Open Access
9 Citations
4,393 Views
14 Pages

Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer

  • Michela Roberto,
  • Giulia Arrivi,
  • Francesca Lo Bianco,
  • Stefano Cascinu and ,
  • Fabio Gelsomino,
  • Francesco Caputo,
  • Krisida Cerma,
  • Michele Ghidini,
  • Margherita Ratti and
  • Federica Mazzuca
  • + 19 authors+ 14 authors

30 August 2020

Background: Although most of the analyses included transverse colon cancers (TCC) among right colon cancer (RCC), it is not completely clear if they present total similarities with RCC or if they have their specific features. Therefore, we present an...

(This article belongs to the Special Issue Management of Colorectal Cancer Metastatic Disease)
  • Review
  • Open Access
49 Citations
9,784 Views
14 Pages

Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions

  • Liang Lu,
  • Xueyan Wan,
  • Yu Xu,
  • Juan Chen and ,
  • Kai Shu and
  • Ting Lei
  • + 1 author+ 0 author

Pituitary adenomas (PAs) are benign lesions; nonetheless, some PAs exhibit aggressive behaviors, which lead to recurrence. The impact of pituitary dysfunction, invasion-related risks, and other complications considerably affect the quality of life of...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Review
  • Open Access
58 Citations
6,095 Views
20 Pages

28 February 2022

Endometrial cancer occurs in up to 29% of women before 40 years of age. Seventy percent of these patients are nulliparous at the time. Decision making regarding fertility preservation in early stage endometrial cancer (ES-EC) is, therefore, a big cha...

(This article belongs to the Special Issue Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Obstetric Outcomes)
  • Article
  • Open Access
11 Citations
10,580 Views
12 Pages

Prognostic Factors After the First Recurrence of Ovarian Cancer

  • Patricia Salas Bolívar,
  • Cristina Gonzalez-Benitez,
  • María Carbonell López,
  • Jesús Díez Sebastian and ,
  • Alicia Hernández Gutiérrez and
  • Ignacio Zapardiel
  • + 1 author+ 0 author

13 January 2025

Objective: Ovarian cancer is the fifth most frequent tumor in women and the second most common gynecological cancer. Recurrence of ovarian cancer develops in up to 50–90% of patients within the first five years after diagnosis. Approximately 70...

(This article belongs to the Special Issue Laparoscopy and Surgery in Gynecologic Oncology)
  • Article
  • Open Access
1 Citations
3,560 Views
19 Pages

Exploratory Study of Associations and Agreement between Prognostic Patient-Registered Factors, Physiotherapists’ Intuitive Synthesis, and Patient-Reported Factors in Whiplash-Associated Disorders

  • Rob A. B. Oostendorp,
  • Gwendolyne G. M. Scholten-Peeters,
  • Jan Mulder,
  • Emiel Van Trijffel and ,
  • Geert M. Rutten,
  • Margot De Kooning,
  • Marjan Laekeman,
  • Nathalie Roussel,
  • Jo Nijs and
  • J. W. Hans Elvers
  • + 5 authors+ 0 author

16 March 2023

Background: A large proportion of people who sustain a whiplash injury will have persistent pain, disability, and participation problems. Several prognostic factors for functional recovery have been reported in the literature but these factors are of...

(This article belongs to the Special Issue Musculoskeletal Rehabilitation: Current Challenges and New Perspectives)
  • Systematic Review
  • Open Access
96 Views
26 Pages

10 November 2026

Background: Evidence of mortality, functional prognosis, and prognostic factors among patients undergoing hemodialysis (HD) with spontaneous intracerebral hemorrhage (ICH) has not been systematically synthesized yet. Objectives: To systematically syn...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
1 Citations
2,225 Views
17 Pages

2 March 2026

Introduction: Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system with a highly heterogeneous clinical course. Early identification of patients at risk of aggressive disease progression is crucial f...

(This article belongs to the Section Neurology)

of 176